{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:18:40Z","timestamp":1763057920917,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004386","name":"Universiti Malaya","doi-asserted-by":"publisher","award":["UMRG-RG503-13HTM"],"award-info":[{"award-number":["UMRG-RG503-13HTM"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-1035-2","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T08:57:14Z","timestamp":1450774634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen"],"prefix":"10.1186","volume":"14","author":[{"given":"Omar A. A.","family":"Bamaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A. K.","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne A. L.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"unstructured":"World Health Organization. World malaria report. Geneva; 2014.","key":"1035_CR1"},{"key":"1035_CR2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1756-3305-7-351","volume":"7","author":"OA Bamaga","year":"2014","unstructured":"Bamaga OA, Mahdy MA, Mahmud R, Lim YA. Malaria in Hadhramout, a southeast province of Yemen: prevalence, risk factors, knowledge, attitude and practices (KAPs). Parasit Vectors. 2014;7:351.","journal-title":"Parasit Vectors."},{"unstructured":"NMCP. Yemen\u2019s national malaria control and elimination strategic plan 2011\u20132015. Ministry and Public Health and Population, primary Health Care Sector, National Malaria Control Programme. 2011.","key":"1035_CR3"},{"key":"1035_CR4","volume-title":"World malaria report, 2012","author":"WHO","year":"2012","unstructured":"World Health Organization. World malaria report. Geneva; 2012."},{"unstructured":"NMCP. Yemen\u2019s national malaria control and elimination strategic plan 2006\u20132010. Ministry and Public Health and Population, primary Health Care Sector, National Malaria Control Programme. 2006.","key":"1035_CR5"},{"key":"1035_CR6","volume-title":"World malaria report, 2011","author":"WHO","year":"2011","unstructured":"World Health Organization. World malaria report. Geneva; 2011."},{"key":"1035_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3855\/jidc.2528","volume":"7","author":"AS Bin Ghouth","year":"2013","unstructured":"Bin Ghouth AS. Availability and prescription practice of anti-malaria drugs in the private health sector in Yemen. J Infect Dev Ctries. 2013;7:404\u201312.","journal-title":"J Infect Dev Ctries."},{"key":"1035_CR8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12936-015-0970-2","volume":"14","author":"AA Adeel","year":"2015","unstructured":"Adeel AA, Saeed NA, Aljasari A, Almohager AM, Galab MH, AlMahdi A, et al. High efficacy of two artemisinin-based combinations: artesunate\u00a0+\u00a0sulfadoxine\u2013pyrimethamine and artemether\u2013lumefantrine for falciparum malaria in Yemen. Malar J. 2015;14:449.","journal-title":"Malar J."},{"key":"1035_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2875-8-89","volume":"8","author":"S Picot","year":"2009","unstructured":"Picot S, Olliaro P, de Monbrison F, Bienvenu A-L, Price RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009;8:89.","journal-title":"Malar J."},{"key":"1035_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1475-2875-10-245","volume":"10","author":"RA Mubjer","year":"2011","unstructured":"Mubjer RA, Adeel AA, Chance ML, Hassan AA. Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications. Malar J. 2011;10:245.","journal-title":"Malar J."},{"key":"1035_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1475-2875-12-244","volume":"12","author":"S Al-Hamidhi","year":"2013","unstructured":"Al-Hamidhi S, Mahdy MA, Al-Hashami Z, Al-Farsi H, Al-Mekhlafi AM, Idris MA, et al. Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen. Malar J. 2013;12:244.","journal-title":"Malar J."},{"key":"1035_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.actatropica.2013.12.022","volume":"132","author":"R Abdul-Ghani","year":"2014","unstructured":"Abdul-Ghani R, Farag HF, Allam AF, Shawky SM. Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine\u2013pyrimethamine partner within the artemisinin-based combination therapy. Acta Trop. 2014;132:39\u201344.","journal-title":"Acta Trop"},{"unstructured":"CSO. Statistical report of Yemen. The Central Statistical Organization. Ministry of Planning and International Cooperation, Yemen. 2013.","key":"1035_CR13"},{"key":"1035_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4269\/ajtmh.1999.60.687","volume":"60","author":"B Singh","year":"1999","unstructured":"Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 1999;60:687\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"1035_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0166-6851(93)90050-8","volume":"58","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58:283\u201392.","journal-title":"Mol Biochem Parasitol"},{"key":"1035_CR16","first-page":"263","volume":"50","author":"G Snounou","year":"1996","unstructured":"Snounou G. Detection and identification of the four malaria parasite species infecting humans by PCR amplification. Methods Mol Biol. 1996;50:263\u201391.","journal-title":"Methods Mol Biol"},{"key":"1035_CR17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"1035_CR18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4269\/ajtmh.2007.76.608","volume":"76","author":"H Tinto","year":"2007","unstructured":"Tinto H, Ouedraogo JB, Zongo I, van Overmeir C, van Marck E, Guiguemde TR, et al. Sulfadoxine\u2013pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg. 2007;76:608\u201313.","journal-title":"Am J Trop Med Hyg"},{"key":"1035_CR19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1128\/AAC.47.4.1347-1354.2003","volume":"47","author":"RJ Pearce","year":"2003","unstructured":"Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother. 2003;47:1347\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"1035_CR20","first-page":"60","volume":"2","author":"T Hall","year":"2011","unstructured":"Hall T. BioEdit: an important software for molecular biology. GERF Bull Biosci. 2011;2:60\u20131.","journal-title":"GERF Bull Biosci."},{"key":"1035_CR21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0163-7258(90)90017-V","volume":"48","author":"JE Hyde","year":"1990","unstructured":"Hyde JE. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacol Therapeut. 1990;48:45\u201359.","journal-title":"Pharmacol Therapeut."},{"key":"1035_CR22","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1073\/pnas.85.23.9109","volume":"85","author":"AF Cowman","year":"1988","unstructured":"Cowman AF, Morry MJ, Biggs BA, Cross G, Foote SJ. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA. 1988;85:9109\u201313.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1035_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","volume":"57","author":"A Gregson","year":"2005","unstructured":"Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57:117\u201345.","journal-title":"Pharmacol Rev"},{"key":"1035_CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1471-4922(01)02185-7","volume":"17","author":"CH Sibley","year":"2001","unstructured":"Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, et al. Pyrimethamine\u2013sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 2001;17:570\u20131.","journal-title":"Trends Parasitol"},{"key":"1035_CR25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0163-7258(91)90074-V","volume":"50","author":"WH Wernsdorfer","year":"1991","unstructured":"Wernsdorfer WH, Payne D. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Therapeut. 1991;50:95\u2013121.","journal-title":"Pharmacol Therapeut."},{"key":"1035_CR26","first-page":"41","volume":"32","author":"C Wongsrichanalai","year":"2001","unstructured":"Wongsrichanalai C, Sirichaisinthop J, Karwacki JJ, Congpuong K, Miller RS, Pang L. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Southeast Asian J Trop Med Public Health. 2001;32:41\u20139.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"1035_CR27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(01)00119-0","volume":"1","author":"P Winstanley","year":"2001","unstructured":"Winstanley P. Modern chemotherapeutic options for malaria. Lancet Infect Dis. 2001;1:242\u201350.","journal-title":"Lancet Infect Dis"},{"key":"1035_CR28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0169-4758(99)01453-2","volume":"15","author":"D Molyneux","year":"1999","unstructured":"Molyneux D, Floyd K, Barnish G, Fevre E. Transmission control and drug resistance in malaria: a crucial interaction. Parasitol Today. 1999;15:238\u201340.","journal-title":"Parasitol Today"},{"key":"1035_CR29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0001-706X(94)90060-4","volume":"56","author":"WH Wernsdorfer","year":"1994","unstructured":"Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trop. 1994;56:143\u201356.","journal-title":"Acta Trop"},{"key":"1035_CR30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.26719\/2010.16.2.146","volume":"16","author":"KA Bashrahil","year":"2010","unstructured":"Bashrahil KA, Bingouth AS, Baruzaig AS. Antimalarial drugs: availability and mode of prescribing in Mukalla, Yemen. East Mediterr Health J. 2010;16:146\u201350.","journal-title":"East Mediterr Health J."},{"key":"1035_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2875-6-9","volume":"6","author":"N Alexander","year":"2007","unstructured":"Alexander N, Sutherland C, Roper C, Cisse B, Schellenberg D. Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance. Malar J. 2007;6:9.","journal-title":"Malar J."},{"key":"1035_CR32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.1098876","volume":"305","author":"C Roper","year":"2004","unstructured":"Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124.","journal-title":"Science"},{"key":"1035_CR33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14737\/journal.jap\/2015\/2.2.40.47","volume":"2","author":"RA Othman","year":"2015","unstructured":"Othman RA, Eldeek HE, Almatary AM, Sayed AA, Alsakaf A. Detection of malaria in healthy blood donors using PCR in an endemic area in Yemen. J Adv Parasitol. 2015;2:40\u20137.","journal-title":"J Adv Parasitol"},{"doi-asserted-by":"crossref","unstructured":"A-Elbasit I, Khalil I, Elbashir M, Masuadi E, Bygbjerg I, Alifrangis M, et al. High frequency of Plasmodium falciparum CICNI\/SGEAA and CVIET haplotypes without association with resistance to sulfadoxine\/pyrimethamine and chloroquine combination in the Daraweesh area, in Sudan. Eur J Clin Microbiol Infect Dis. 2008;27:725\u201332.","key":"1035_CR34","DOI":"10.1007\/s10096-008-0499-1"},{"doi-asserted-by":"crossref","unstructured":"Al-Saai S, Kheir A, Abdel-Muhsin A-MA, Al-Ghazali A, Nwakanma D, Swedberg G, et al. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine\u2013pyrimethamine (SP) resistance in eastern Sudan. Infect Genet Evol. 2009;9:778\u201383.","key":"1035_CR35","DOI":"10.1016\/j.meegid.2009.04.010"},{"key":"1035_CR36","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.meegid.2012.03.011","volume":"12","author":"HM Al-Farsi","year":"2012","unstructured":"Al-Farsi HM, Al-Hashami ZS, Dajem SMB, Al-Sheikh AAH, Al-Qahtani A, Beja-Pereira A, et al. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia. Infect Genet Evol. 2012;12:1253\u20139.","journal-title":"Infect Genet Evol."},{"key":"1035_CR37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-3156.2009.02369.x","volume":"14","author":"M Menegon","year":"2009","unstructured":"Menegon M, Pearce RJ, Inojosa WO, Pisani V, Abel PM, Matondo A, et al. Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola. Trop Med Int Health. 2009;14:1251\u20137.","journal-title":"Trop Med Int Health."},{"key":"1035_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.actatropica.2005.06.003","volume":"95","author":"H Sendagire","year":"2005","unstructured":"Sendagire H, Kaddumukasa M, Ndagire D, Aguttu C, Nassejje M, Pettersson M, et al. Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative. Acta Trop. 2005;95:172\u201382.","journal-title":"Acta Trop"},{"key":"1035_CR39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/jac\/dkp467","volume":"65","author":"MK Bouyou-Akotet","year":"2010","unstructured":"Bouyou-Akotet MK, Mawili-Mboumba DP, de Dieu Tchantchou T, Kombila M. High prevalence of sulfadoxine\/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine\/pyrimethamine in Gabon. J Antimicrob Chemother. 2010;65:438\u201341.","journal-title":"J Antimicrob Chemother"},{"key":"1035_CR40","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.ijid.2009.11.035","volume":"14","author":"S Zakeri","year":"2010","unstructured":"Zakeri S, Farahani MS, Afsharpad M, Salehi M, Raeisi A, Djadid ND. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine\u2013pyrimethamine. Int J Infect Dis. 2010;14:e123\u20138.","journal-title":"Int J Infect Dis."},{"key":"1035_CR41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1475-2875-12-96","volume":"12","author":"GR Awab","year":"2013","unstructured":"Awab GR, Pukrittayakamee S, Jamornthanyawat N, Yamin F, Dondorp AM, Day NP, et al. Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan. Malar J. 2013;12:96.","journal-title":"Malar J."},{"key":"1035_CR42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2222-1808(12)60008-5","volume":"2","author":"S Das","year":"2012","unstructured":"Das S, Chakraborty SP, Tripathy S, Hati AK, Roy S. Association between prevalence of pyrimethamine resistance and double mutation in pfdhfr gene in West Bengal, India. Asian Pac J Trop Dis. 2012;2:31\u20135.","journal-title":"Asian Pac J Trop Dis."},{"key":"1035_CR43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijantimicag.2013.01.005","volume":"41","author":"S Das","year":"2013","unstructured":"Das S, Chakraborty SP, Hati A, Roy S. Malaria treatment failure with novel mutation in the Plasmodium falciparum dihydrofolate reductase (pfdhfr) gene in Kolkata, West Bengal, India. Int J Antimicrob Agents. 2013;41:447\u201351.","journal-title":"Int J Antimicrob Agents"},{"key":"1035_CR44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/aje\/kwf030","volume":"156","author":"F Mendez","year":"2002","unstructured":"Mendez F, Munoz A, Carrasquilla G, Jurado D, Arevalo-Herrera M, Cortese JF, et al. Determinants of treatment response to sulfadoxine\u2013pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol. 2002;156:230\u20138.","journal-title":"Am J Epidemiol"},{"key":"1035_CR45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4269\/ajtmh.2002.67.225","volume":"67","author":"I Khalil","year":"2002","unstructured":"Khalil I, Alifrangis M, R\u00f8nn AM, Gabar HA, Jelinek T, Satti GM, et al. Pyrimethamine\/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase\/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome. Am J Trop Med Hyg. 2002;67:225\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1035_CR46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine\u2013pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Int J Infect Dis. 2002;185:380\u20138.","journal-title":"Int J Infect Dis."},{"key":"1035_CR47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.meegid.2015.01.020","volume":"31","author":"M Rouhani","year":"2015","unstructured":"Rouhani M, Zakeri S, Pirahmadi S, Raeisi A, Djadid ND. High prevalence of pfdhfr\u2013pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine\u2013pyrimethamine in combination with artesunate as first-line treatment in Iran. Infect Genet Evol. 2015;31:183\u20139.","journal-title":"Infect Genet Evol."},{"key":"1035_CR48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1475-2875-13-152","volume":"13","author":"SI Matondo","year":"2014","unstructured":"Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, van Zwetselaar M, et al. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania. Malar J. 2014;13:152.","journal-title":"Malar J."},{"key":"1035_CR49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2875-9-9","volume":"9","author":"A Dicko","year":"2010","unstructured":"Dicko A, Sagara I, Djimd\u00e9 AA, Tour\u00e9 SO, Traore M, Dama S, et al. Molecular markers of resistance to sulphadoxine\u2013pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Malar J. 2010;9:9.","journal-title":"Malar J."},{"key":"1035_CR50","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-3156.2005.01471.x","volume":"10","author":"FP Mockenhaupt","year":"2005","unstructured":"Mockenhaupt FP, Bousema TJ, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, et al. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine\u2013pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop Med Int Health. 2005;10:901\u20138.","journal-title":"Trop Med Int Health."},{"key":"1035_CR51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1475-2875-12-413","volume":"12","author":"A Ogouy\u00e8mi-Hounto","year":"2013","unstructured":"Ogouy\u00e8mi-Hounto A, Ndam NT, Fad\u00e9gnon G, Azagnandji C, Bello M, Moussiliou A, et al. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine\/pyrimethamine in asymptomatic children in Northern Benin. Malar J. 2013;12:413.","journal-title":"Malar J."},{"doi-asserted-by":"crossref","unstructured":"Ogouy\u00e8mi-Hounto A, Ndam NT, Gazard DK, d\u2019Almeida S, Koussihoude L, Ollo E, et al. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine\/pyrimethamine in Benin seven years after the change of malaria treatment policy. Malar J. 2013;12:147.","key":"1035_CR52","DOI":"10.1186\/1475-2875-12-147"},{"key":"1035_CR53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1475-2875-10-214","volume":"10","author":"P Mula","year":"2011","unstructured":"Mula P, Fern\u00e1ndez-Mart\u00ednez A, de Lucio A, Ramos JM, Reyes F, Gonz\u00e1lez V, et al. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia. Malar J. 2011;10:214.","journal-title":"Malar J."},{"key":"1035_CR54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpddr.2013.07.001","volume":"3","author":"D Ndiaye","year":"2013","unstructured":"Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, et al. Polymorphism in dhfr\/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal. Int J Parasitol Drugs Drug Resist. 2013;3:135\u201342.","journal-title":"Int J Parasitol Drugs Drug Resist."},{"unstructured":"WHO. Guidelines for the treatment of malaria, 3rd edn. World Health Organization: Geneva. 2015. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/ .","key":"1035_CR55"},{"key":"1035_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.actatropica.2015.05.013","volume":"149","author":"OA Bamaga","year":"2015","unstructured":"Bamaga OA, Mahdy MA, Lim YA. Survey of chloroquine-resistant mutations in the Plasmodium falciparum pfcrt and pfmdr-1 genes in Hadhramout, Yemen. Acta Trop. 2015;149:59\u201363.","journal-title":"Acta Trop."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-1035-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T17:19:40Z","timestamp":1567444780000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-1035-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"516"}}